Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. López-Abente (Madrid, Spain), C. Benito-Villalvilla (Madrid, Spain), X. Jaumont (Basel, Switzerland), P. Pfister (Basel, Switzerland), P. Tassinari (Basel, Switzerland), O. Palomares (Madrid, Spain). Late Breaking Abstract - IgE-FceR1 cross-linking impairs the capacity of plasmacytoid dendritic cells to induce in vitro functional regulatory T cells which can be restored by Omalizumab. 3803

Member's Comments

No comment yet.

Related content which might interest you: Exposure of dendritic cells to biomedical nanoparticles down-regulates their capacity for antigen-specific CD4+ T cell stimulation Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009 Effects of dendritic cells overexpressing Serrate1 on the polarization of CD4+CD25+ T cells and the production of inhibitory cytokines in vitro Source: Eur Respir J 2005; 26: Suppl. 49, 25s Year: 2005 The effect of Immunotherapy on the expression of costimulatory pathway molecules on dendritic cells and T cells in asthmatic mice Source: Eur Respir J 2003; 22: Suppl. 45, 483s Year: 2003 Mast cell activation leads to migration of T-cells in vitro Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients Year: 2007 Human myeloid lung dendritic cells are strong inducers of T cell proliferation compared to plasmacytoid lung dendritic cells Source: Annual Congress 2005 - Basic mechanisms in asthma and COPD: new insights Year: 2005 Increased pro-inflammatory regulatory T Cells correlate with the plasticity of T helper cell differentiation in asthma Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Exposure of dendritic cells to biomedical nanoparticles decreases antigen processing capacity and specific CD4+ T cell stimulation Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010 Comprehensive characterisation of T helper cells, cytotoxic T cells and novel invariant T cell phenotypes in human asthma Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Effect of OVA activated tolerogenic mouse bone marrow dendritic cells on the production of IL-17 in vitro Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Late Breaking Abstract - Benralizumab treatment reduces the high-affinity IgE receptor on plasmacytoid dendritic cells in patients with severe asthma Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 Surfactant decreases LPS-dependent CD4+ T cell stimulation by dendritic cells Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009 Activin-A is a critical inducer of human CD4+ICOS+IL-10-secreting regulatory T cells that suppress allergen-driven T cell responses in vitro and experimental asthma in a humanized mouse model in vivo Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 High concentration of antigen induces allergic mice T cells anergy with depressing CD86 expression on antigen-presenting cells Source: Eur Respir J 2002; 20: Suppl. 38, 28s Year: 2002 Role of dendritic cells and T-regulatory cells in COPD Source: Annual Congress 2013 –Immunopathology of COPD: contribution of advancements of new therapeutic agents Year: 2013 Airway epithelial cells activate anti-viral pathways in human dendritic cells Source: Annual Congress 2009 - Lung cell biology and immunology Year: 2009 Induction of enhanced antitumor immunity by fusion of Interleukin-12 gene-modified cancer cells with dendritic cells Source: Eur Respir J 2003; 22: Suppl. 45, 199s Year: 2003 Organic dust induces intracellular production of cytokines in monocytes, NK and T cells in vitro Source: Eur Respir J 2001; 18: Suppl. 33, 113s Year: 2001 Microvesicles from human activated dendritic cells are released as a function of danger signals and fuse with resting dendritic cells allowing them to present allo-antigens Source: Eur Respir J 2006; 28: Suppl. 50, 340s Year: 2006 CD38 gene-modified dendritic cells inhibit murine asthma development through increasing IL-12 production and promoting Th1 cell differentiation Source: International Congress 2016 – Immune responses in the lung Year: 2016 Omalizumab enhances the percentage of GARP cells in both regulatory and terminally differentiated effector Th cells in severe allergic asthmatics Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018